Paroxetine (Paxil)

Subscribe to Selected New Research on Paroxetine

981 relevant articles (162 outcomes, 235 trials/studies) found for this Drug

Description: A serotonin uptake inhibitor that is effective in the treatment of depression.

Also Known As:

Paxil; Seroxat; Aropax; Paroxetine Hydrochloride; BRL-29060; FG-7051; Paroxetine Acetate; Paroxetine Hydrochloride, Hemihydrate; Paroxetine Maleate; Paroxetine, cis-(+)-Isomer; Paroxetine, cis-(-)-Isomer; Paroxetine, trans-(+)-Isomer; Acetate, Paroxetine; BRL 29060; BRL29060; Hemihydrate Paroxetine Hydrochloride; Hydrochloride, Hemihydrate Paroxetine; Hydrochloride, Paroxetine; Maleate, Paroxetine; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S-trans)-

Relationship Network

Drug Context: Research Results

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

Piperidines: 7

Paroxetine: 981

N-(3-fluoropropyl)paroxetine

Experts

1.	Stein, Dan J: 6 articles (04/2007 - 02/2002)
2.	Wagner, Karen Dineen: 6 articles (06/2006 - 01/2003)
3.	Carpenter, David J: 6 articles (06/2006 - 11/2004)
4.	Simon, Naomi M: 5 articles (05/2008 - 09/2003)
5.	Pollack, Mark H: 5 articles (05/2008 - 01/2003)
6.	Stein, Murray B: 5 articles (03/2008 - 01/2002)
7.	Zaninelli, R: 5 articles (12/2001 - 01/2000)
8.	Krulewicz, Stan: 4 articles (03/2008 - 04/2006)
9.	Beebe, Katherine L: 4 articles (05/2007 - 06/2003)
10.	Denys, Damiaan: 4 articles (05/2007 - 12/2003)

Related Diseases

1.	Anxiety Disorders (Anxiety Disorder) 05/01/2005 - "Paroxetine has been the most studied agent in social anxiety disorder and has been shown to be effective in short-term, fixed- and flexible-dose placebo-controlled trials, as well as in long-term treatment" 01/01/2002 - "CONCLUSION: Paroxetine, 20 mg/day, is an effective and safe treatment for patients with generalized social anxiety disorder and significantly improves social anxiety, avoidance of social interactions, social disability, and overall clinical condition" 12/01/2004 - "RESULTS: In general, across the range of anxiety disorders studied, in both short- and long-term studies, remission rates were higher for paroxetine compared with placebo, using disorder-specific, global, and functional remission criteria both individually and combined" 02/01/2007 - "While the overall efficacy of paroxetine appears to be comparable with other SSRIs in the treatment of major depression, it is approved for use in a wider variety of anxiety disorders than any other antidepressant" 01/01/2003 - "An abundance of data have been accumulated from clinical investigations demonstrating the efficacy of paroxetine in the treatment of major depression and anxiety disorders" Get all the results and reference details, order at left...
2.	Panic Disorder (Panic Attack) 02/01/1997 - "Paroxetine was statistically significantly more effective than placebo throughout the long-term study with respect to reduction from baseline of full panic attacks, and at the end of treatment with respect to the proportion of patients who eventually experienced no panic attacks" 09/01/1999 - "Paroxetine treatment (19.7 +/- 4.7 mg/day for 105 +/- 37 days) resulted in a significant improvement in the frequency and intensity of panic attacks and also on the state anxiety inventory" 09/01/1995 - "Paroxetine plus cognitive therapy was significantly more effective than placebo plus cognitive therapy in the treatment of panic disorder." 01/01/1998 - "OBJECTIVE: This study was designed to determine the minimum paroxetine dose effective for treating panic disorder" 02/01/1997 - "Paroxetine has been shown to be effective in panic disorder in three 10- to 12-week studies" Get all the results and reference details, order at left...
3.	Post-Traumatic Stress Disorders (PTSD) 02/01/1998 - "Because paroxetine seems a highly promising treatment for all three symptom clusters of PTSD, a placebo-controlled clinical trial is warranted." 10/01/2003 - "Paroxetine is effective in the short-term treatment of PTSD, resulting in significantly better response and remission rates than placebo, improving sleep disturbance and reducing each of the symptom clusters of PTSD, as well as the disability associated with this condition" 12/01/2001 - "Moreover, paroxetine treatment resulted in statistically significant improvement compared to placebo on all three PTSD symptom clusters (reexperiencing, avoidance/numbing, and hyperarousal), social and occupational impairment, and comorbid depression" 11/01/2001 - "At week 12, compared with the placebo group (N = 156), the paroxetine group (N = 151) showed significantly greater reduction of PTSD symptoms on both of the primary and all of the secondary outcome measures" 02/01/1998 - "The authors hypothesized that paroxetine might be effective in PTSD, based on findings of its particular efficacy for anxiety and agitation in studies of depressed patients" Get all the results and reference details, order at left...
4.	Phobic Disorders (Phobia) 09/01/1998 - "Paroxetine, the most thoroughly studied SSRI, has been shown to be effective in treating the symptoms of generalized social phobia in a large-scale, placebo-controlled trial" 08/01/2003 - "Treatment with paroxetine was associated with a significant improvement in standard social-phobia scores, although most patients remained symptomatic" 10/01/2001 - "Subjects were 14 patients with generalized social phobia who were less than "very much improved" on the Clinical Global Impression scale after at least 10 weeks of treatment with a maximally tolerated dose of paroxetine" 12/01/2002 - "Compared with placebo, paroxetine treatment significantly (P<.001) improved the symptoms of social anxiety as shown on the Liebowitz Social Anxiety Scale, Social Phobia Inventory, Sheehan Disability Scale, Symptom Checklist-90 score, and EuroQol visual analogue scale, indicating decreased disability and increased well-being" 08/01/1999 - "CONCLUSIONS: Paroxetine is an effective, well-tolerated treatment for patients with social phobia." Get all the results and reference details, order at left...
5.	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 11/01/2004 - "CONCLUSIONS: Paroxetine is an effective and generally well-tolerated treatment for obsessive-compulsive disorder in children and adolescents." 09/01/2003 - "CONCLUSION: Paroxetine doses of 40 mg/day and 60 mg/day (but not 20 mg/day) are effective in treating acute obsessive-compulsive disorder" 08/01/2004 - "The efficacy of paroxetine in the treatment of obsessive-compulsive disorder in Western populations is well established" 01/01/2003 - "Obsessive-compulsive disorder: implications of the efficacy of an SSRI, paroxetine." 07/01/2006 - "This paper presents several clinical trials of paroxetine carried out, and discusses and reviews the therapeutic strategies for obsessive-compulsive disorder." Get all the results and reference details, order at left...
261 Diseases and 981 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Serotonin (5 Hydroxytryptamine)
2.	venlafaxine (Effexor)
3.	Sertraline (Zoloft)
4.	Fluoxetine (Prozac)
5.	Serotonin Uptake Inhibitors (Serotonin Reuptake Inhibitors)
6.	Antidepressive Agents (Antidepressants)
7.	Citalopram (Escitalopram)
8.	Fluvoxamine (Luvox)
9.	Imipramine (Janimine)
10.	Clomipramine (Anafranil)
464 Drugs and Important Bio-Agents and 581 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Aftercare (After-Treatment)
3.	Phototherapy (Light Therapy)
4.	Lower Body Negative Pressure
5.	Pancreaticoduodenectomy
9 Therapies and Procedures and 27 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>